20641 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
Sub-classes:COMPOSITION FOR ENDOMETRIAL REGENERATION CONTAINING A UTERUS-DERIVED DECELLULARIZED EXTRACELLULAR MATRIX (UDECM) AND A MANUFACTURING METHOD THEREFOR
#2CHIMERIC OVARIAN FOLLICLE-BASED THERAPY TO TREAT FEMALE INFERTILITY
#3GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#4PRECURSORY REGULATORY CYTOTROPHOBLAST CELLS AND USES THEREOF
#5Effective Interventions With Aging and Diseases Of Aging Of Human and Their Consequences
#6HUMAN TROPHOBLAST STEM CELLS AND USES THEREOF
#7IN VITRO GENERATION OF ORGANIZED 3D CELL STRUCTURES INCLUDING HEAD-TRUNK EMBRYO-LIKE STRUCTURES, USING EPIGENETIC REMODELING FACTORS-MICROFLUIDIC PLATFORM SUITABLE FOR THEIR GENERATION
#8COMPOSITIONS AND METHODS RELATING TO POOLED FETAL SUPPORT TISSUE
#9IMMUNOISOLATION DEVICE
#10FOLLICULAR FLUID METHOD
#11Compounds for use in regulating follicle maturation
#12ARTIFICIAL PLACENTA VACCINE FOR ORGAN TRANSPLANTATION
#13VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#14METHOD FOR IDENTIFYING A MAMMAL RECEPTIVE TO EMBRYO TRANSFER
#15METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM
#16MRNA-ENCODED ANTIBODIES FOR CONTRACEPTION
#17METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS
#18METHOD FOR PREPARATION OF BLASTOCYST
#19CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-BETA
#20COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER
#21METHODS TO REBALANCE THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS
#22PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
#23DYNAMIC COVALENTLY LINKED HYDROGELS AS STABILIZATION NETWORK PLATFORMS
#24USE OF OVARIAN-DERIVED HYDROGELS FOR RESTORATION OF REPRODUCTIVE FUNCTION AND HEALTH IN WOMEN
#25METHOD OF TREATING GLIOBLASTOMA
#26Variant ICOS ligand immunomodulatory proteins and related compositions and methods
#27METHOD FOR PREPARATION OF BLASTOCYST
#28FETAL TISSUE EXTRACT, METHODS FOR PRODUCING THE EXTRACT, AND THE USE THEREOF
#29Precursory regulatory cytotrophoblast cells and uses thereof
#30GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#31FOLLICULAR FLUID
#32Human trophoblast stem cells and uses thereof
#33METHODS FOR MAKING AND USING MODIFIED OOCYTES
#34Immunoisolation device
#35Compounds for use in regulating follicle maturation
#36Magnetic Nanoparticles for use in Assisted Reproduction
#37EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER
#38Precursory regulatory cytotrophoblast cells and uses thereof
#39Human trophoblast stem cells and uses thereof
#40HEMORRHOID TREATMENT SYSTEMS AND METHOD
#41VARIANT ICOS LIGAND IMMUNOMODULATORY PROTEINS AND RELATED COMPOSITIONS AND METHODS
#42Method for identifying a mammal receptive to embryo transfer
#43COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS OR CIRRHOSIS, COMPRISING EXPRESSION OR ACTIVITY ENHANCER OF TIF1y AS ACTIVE INGREDIENT
#44Methods for making and using modified oocytes
#45GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#46Mammalian cells devoid of lactate dehydrogenase activity
#47OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE
#48Sperm activator and uses thereof
#49Methods of enhancing chromosomal homologous recombination
#50Living cell transplanting tool
#51Targeted Therapeutic Proteins
#52Extracellular matrix compositions for the treatment of cancer
#53Use of Antisecretory Factor (AF) in Glioblastoma Treatment
#54FOLLICULAR FLUID
#55Hybrid Dairy Cattle and Systems for Maximizing Hybrid Advantage
#56Hybrid dairy cattle and systems for maximizing hybrid advantage
#57Hybrid dairy cattle and systems for maximizing hybrid advantage
#58MITOCHONDRIAL MICROINJECTION OF OOCYTES
#59In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells
#60Adrenomedullin therapy to improve fetal implantation
#61Artificial micro-gland
#62Methods of enhancing female fertility
#63Immunoisolation device
#64METHODS AND ARTICLES OF MANUFACTURE FOR THE TREATMENT OF ANIMALS
#65Glucagon-like-peptide-2 (GLP-2) analogues
#66METHODS FOR GROWTH AND MATURATION OF OVARIAN FOLLICLES
#67Stimulation of ovarian follicle development and oocyte maturation
#68Human trophoblast stem cells and uses thereof
#69Methods to differentiate stem cells into hormone-producing cells
#70Pharmaceutical composition for inhibiting expression of CD47 in tumor cells and use of same
#71Isolated Populations of Female Germline Stem Cells and Cell Preparations and Compositions Thereof
#72Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#73Targeted therapeutic proteins
#74Single nucleotide polymorphisms associated with bull fertility
#75Human disease mitigation with food formulation
#76Artificial ovary
#77Immortalized stem cell, compositions, preparations and uses thereof
#78STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION
#79METHODS OF MODULATING BONE REMODELING
#80Combination immunotherapy approach for treatment of cancer
#81METHODS FOR PREVENTING TRANSPLANTATION-INDUCED FOLLICLE ACTIVATION
#82Regionalised Endoderm Cells and Uses Thereof
#83Methods and articles of manufacture for cosmetic results
#84GONAD-DERIVED SIDE POPULATION STEM CELLS
#85Methods for making and using modified oocytes
#86Methods for growth and maturation of ovarian follicles
#87Methods of modulating bone remodeling
#88Extracellular matrix compositions for the treatment of cancer
#89MANIPULATION OF OVARIAN PRIMORDIAL FOLLICLES
#90Pancreatic islets of transgenic LEA29Y animals for treating diabetes
#91Glucagon-like-peptide-2 (GLP-2) analogues
#92ENCAPSULATED CELLS FOR TREATING LOW TESTOSTERONE IN MALE SUBJECTS
#93Hybrid dairy cattle and systems for maximizing hybrid advantage
#94Method for manufacturing digestive enzyme antibody and egg having same, and for manufacturing processed product containing egg as ingredient thereof and composition including antibody
#95METHODS OF GENERATING INTERMEDIATE MESODERM CELLS FROM HUMAN PLURIPOTENT STEM CELLS
#96Methods and Compositions for Ex Vivo Generation of Developmentally Competent Eggs from Germ Line Cells Using Autologous Cell Systems
#97Encapsulated cells for hormone replacement therapy
#98Encapsulated cells for hormone replacement therapy
#99Targeted therapeutic proteins
#100Medicament for treating muscle and skeletal diseases
#101Methods of treating diseases with human trophoblast stem cells
#102Composition for treating inflammatory brain diseases which includes stem cell as active ingredient
#103Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues
#104Methods to rebalance the hypothalamic-pituitary-gonadal axis
#105Bandage containing foetal fibroblasts and keratinocytes
#106Use of cellular extracts for skin rejuvenation
#107Single nucleotide polymorphisms associated with bull fertility
#108Medicament for treating muscle and skeletal diseases
#109REGIONALISED ENDODERM CELLS AND USES THEREOF
#110STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION
#111DIETARY SUPPLEMENTS FOR PROMOTION OF GROWTH, REPAIR, AND MAINTENANCE OF BONE AND JOINTS
#112Human Persistent Fetal Vasculature Neural Progenitors for Transplantation in the Inner Retina
#113Glucagon-like-peptide-2 (GLP-2) analogues
#114METHOD FOR HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT
#115METHOD FOR THE HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT
#116TARGETED THERAPEUTIC PROTEINS
#117METHOD FOR OBTAINING MAB-LIKE CELLS AND USES THEREOF
#118Mammalian fetal pulmonary cells and therapeutic use of same
#119Stimulation of ovarian follicle development and oocyte maturation
#120Isolated populations of female germline stem cells and cell preparations and compositions thereof
#121METHOD OF ISOLATING HUMAN NEUROEPITHELIAL PRECURSOR CELLS FROM HUMAN FETAL TISSUE
#122Encapsulated cells for hormone replacement therapy
#123Methods of modulating bone remodeling
#124Pancreatic islets of transgenic LEA29Y animals for treating diabetes
#125Methods for isolating early neurons and neuroblasts
#126Methods for promoting hair growth
#127Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
#128Stem cell secreted product derived compositions for wound treatment
#129Compositions and methods for enhancing bioenergetic status in female germ cells
#130Method for identifying a mammal receptive to embryo transfer
#131Human trophoblast stem cells and use thereof
#132Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#133Glucagon-like-peptide-2 (GLP-2) analogues
#134Method of isolating human neuroepithelial precursor cells from human fetal tissue
#135Targeted therapeutic proteins
#136PRE-NATAL MESENCHYMAL STEM CELLS
#137Regionalised endoderm cells and uses thereof
#138Method for obtaining female germline stem cells and uses thereof
#139EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION
#140COMPOSITIONS AND METHODS FOR GROWING EMBRYONIC STEM CELLS
#141Bone marrow targeting peptides
#142Rejuvenation or preservation of germ cells
#143Rejuvenation or preservation of germ cells
#144Rejuvenation or preservation of germ cells
#145Rejuvenation or preservation of germ cells
#146Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
#147Human trophoblast stem cells and use thereof
#148Treatment of inflammatory bowel disease using glucagon-like-peptide-2 (GLP-2) analogues
#149MULTIPOTENT NEURAL CELLS
#150Glucagon-like-peptide-2 (GLP-2) analogues
#151Extracellular matrix compositions for the treatment of cancer
#152STEM CELLS FOR USE IN LOCATING AND TARGETING TUMOR CELLS
#153Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#154Artificial micro-gland
#155Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
#156Manipulation of ovarian primordial follicles
#157EXTRACELLULAR MATRIX COMPOSITIONS
#158UNACTIVATED OOCYTES AS CYTOPLAST RECIPIENTS FOR NUCLEAR TRANSFER
#159Methods for Reprogramming Adult Somatic Cells and Uses Thereof
#160Stem cell secreted product derived compositions for wound treatment
#161METHODS FOR PROMOTING HAIR GROWTH
#162Extracellular matrix compositions for the treatment of cancer
#163Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells
#164Vascularized islets and methods of producing same
#165Methods of Minimizing Immunological Rejection of A Nuclear Transfer Fetus
#166Anti-cancer immune-modulating agent
#167Differentiating human trophoblast stem cells in mammalian straitum
#168TARGETED THERAPEUTIC PROTEINS
#169Methods for enhancing fertility comprising administration of transfer factor
#170Method of isolating human neuroepithelial precursor cells from human fetal tissue
#171Extracellular Matrix Compositions for Tissue Regeneration
#172Methods and systems for treating ischemic tissues
#173CRYOPRESERVATION OF HUMAN BLASTOCYST-DERIVED STEM CELLS BY USE OF A CLOSED STRAW VITRIFICATION METHOD
#174Method for targeting lysosomal enzymes
#175Anti-hypertensive functional food products
#176AUGMENTATION AND REPAIR OF SPINCTER DEFECTS WITH CELLS INCLUDING MESENCHYMAL CELLS
#177EXTRACELLULAR MATRIX COMPOSITIONS FOR TISSUE REGENERATION
#178Augmentation and repair of spincter defects with cells including mesenchymal cells
#179Compositions Containing Agm Cells And Methods Of Use Thereof
#180Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#181Glucagon-like-peptide-2 (GLP-2) analogues
#182Methods of treating chemotherapy-induced diarrhea/mucositis using glucagon-like-peptide-2(GLP-2)analogues
#183Cytotherapeutics, cytotherapeutic units and methods for treatments using them
#184Methods of ungulate nuclear transfer
#185Quiescent cell populations for nuclear transfer
#186Methods of ungulate nuclear transfer
#187Unactivated oocytes as cytoplast recipients for nuclear transfer
#188Human trophoblast stem cells and use thereof
#189Stem cells for use in locating and targeting tumor cells
#190Mammalian cultured inner cell mass cell culture using a quiescent cell as nuclear
#191Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
#192Skin care formulation containing whole egg powder
#193Systems and methods for augmenting tissue volume
#194Mammalian cultured inner cell mass cell culture using a g1 cell as nuclear donor
#195Compositions comprising female germline stem cells and methods of use thereof
#196Methods of and pharmaceutical compositions for improving implantation of embryos
#197Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
#198Unactivated oocytes as cytoplast recipients for nonprimate mammalian and pig nuclear transfer
#199Method of isolating human neuroepithelial precursor cells from human fetal tissue
#200Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants
#201Serial nuclear transfer of ungulate embryos
#202Methods and compositions to aid breast enhancement
#203Unactivated ungulate oocytes to produce a cloned ungulate by nuclear transfer
#204Cloning ungulates from a quiescent donor cell
#205Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP)
#206Method of extracting follicular fluid and application thereof in treatment of various medical conditions
#207Wound covering and method of preparation